The University of Oxford candidate, led by Sarah Gilbert, might be through human trials in September. AstraZeneca has lined up agreements to produce 2 billion doses. Could this be the one?
Hosts: Carol Massar and Jason Kelly. Producer: Doni Holloway.
See omnystudio.com/listener for privacy information.
Fler avsnitt av Bloomberg Businessweek
Visa alla avsnitt av Bloomberg BusinessweekBloomberg Businessweek med Bloomberg finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
